BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 38528753)

  • 1. Histopathology, mRNA expression profile, and donor-derived cell-free DNA for assessment of rejection in pediatric heart transplantation.
    O'Halloran CP; Tannous P; Arva NC; Thrush PT; Monge M; Joong A; Magnetta DA
    Pediatr Transplant; 2024 May; 28(3):e14705. PubMed ID: 38528753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between donor-derived cell-free DNA and tissue-based rejection-related transcripts in heart transplantation.
    Lee DH; Usmani A; Wu R; Wicks T; Noh CY; Burke R; Ravichandran V; Wolf-Doty T; Dumitru I; Oliveira GH; Berman P; Mackie B
    J Heart Lung Transplant; 2024 Jul; 43(7):1118-1125. PubMed ID: 38373559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evolving the surveillance and workup of heart transplant rejection: A real-world analysis of the Molecular Microscope Diagnostic System.
    Alam A; Van Zyl J; Paul Milligan G; Michelle McKean S; Patel R; Anne Hall S
    Am J Transplant; 2022 Oct; 22(10):2443-2450. PubMed ID: 35514138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Donor-Derived Cell-Free DNA for the Detection of Heart Allograft Injury: The Impact of the Timing of the Liquid Biopsy.
    Verhoeven JGHP; Hesselink DA; Peeters AMA; de Jonge E; von der Thüsen JH; van Schaik RHN; Matic M; Baan CC; Manintveld OC; Boer K
    Transpl Int; 2022; 35():10122. PubMed ID: 35387397
    [No Abstract]   [Full Text] [Related]  

  • 5. Cell-Free DNA to Detect Heart Allograft Acute Rejection.
    Agbor-Enoh S; Shah P; Tunc I; Hsu S; Russell S; Feller E; Shah K; Rodrigo ME; Najjar SS; Kong H; Pirooznia M; Fideli U; Bikineyeva A; Marishta A; Bhatti K; Yang Y; Mutebi C; Yu K; Kyoo Jang M; Marboe C; Berry GJ; Valantine HA;
    Circulation; 2021 Mar; 143(12):1184-1197. PubMed ID: 33435695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Donor-derived cell-free DNA: An independent biomarker in kidney transplant patients with antibody-mediated rejection.
    Cheng D; Liu F; Xie K; Zeng C; Li X; Ni X; Ge J; Shu L; Zhou Y; Shi H; Liu H; Chen J
    Transpl Immunol; 2021 Dec; 69():101404. PubMed ID: 33971294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation of Donor-derived Cell-free DNA With Histology and Molecular Diagnoses of Kidney Transplant Biopsies.
    Gupta G; Moinuddin I; Kamal L; King AL; Winstead R; Demehin M; Kang L; Kimball P; Levy M; Bhati C; Massey HD; Kumar D; Halloran PF
    Transplantation; 2022 May; 106(5):1061-1070. PubMed ID: 34075006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Building a tissue-based molecular diagnostic system in heart transplant rejection: The heart Molecular Microscope Diagnostic (MMDx) System.
    Halloran PF; Potena L; Van Huyen JD; Bruneval P; Leone O; Kim DH; Jouven X; Reeve J; Loupy A
    J Heart Lung Transplant; 2017 Nov; 36(11):1192-1200. PubMed ID: 28662985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between blood and tissue-based rejection-related transcripts in heart transplantation.
    Lee DH; Usmani A; Ravichandran V; Wicks T; Wu R; Wolf-Doty T; Dumitru I; Berman P; Oliveira GH; Mackie B
    J Heart Lung Transplant; 2024 Mar; 43(3):359-368. PubMed ID: 37730189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Donor-derived cell-free DNA accurately detects acute rejection in lung transplant patients, a multicenter cohort study.
    Jang MK; Tunc I; Berry GJ; Marboe C; Kong H; Keller MB; Shah PD; Timofte I; Brown AW; Ponor IL; Mutebi C; Philogene MC; Yu K; Iacono A; Orens JB; Nathan SD; Agbor-Enoh S
    J Heart Lung Transplant; 2021 Aug; 40(8):822-830. PubMed ID: 34130911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Monitoring of Donor-derived Cell-free DNA in Kidney Transplantation.
    Filippone EJ; Farber JL
    Transplantation; 2021 Mar; 105(3):509-516. PubMed ID: 32732615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Late manifestation of alloantibody-associated injury and clinical pulmonary antibody-mediated rejection: Evidence from cell-free DNA analysis.
    Agbor-Enoh S; Jackson AM; Tunc I; Berry GJ; Cochrane A; Grimm D; Davis A; Shah P; Brown AW; Wang Y; Timofte I; Shah P; Gorham S; Wylie J; Goodwin N; Jang MK; Marishta A; Bhatti K; Fideli U; Yang Y; Luikart H; Cao Z; Pirooznia M; Zhu J; Marboe C; Iacono A; Nathan SD; Orens J; Valantine HA; Khush K
    J Heart Lung Transplant; 2018 Jul; 37(7):925-932. PubMed ID: 29500138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Molecular Microscope Diagnostic System: Assessment of Rejection and Injury in Heart Transplant Biopsies.
    Halloran PF; Madill-Thomsen KS
    Transplantation; 2023 Jan; 107(1):27-44. PubMed ID: 36508644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Applying rigor and reproducibility standards to assay donor-derived cell-free DNA as a non-invasive method for detection of acute rejection and graft injury after heart transplantation.
    Agbor-Enoh S; Tunc I; De Vlaminck I; Fideli U; Davis A; Cuttin K; Bhatti K; Marishta A; Solomon MA; Jackson A; Graninger G; Harper B; Luikart H; Wylie J; Wang X; Berry G; Marboe C; Khush K; Zhu J; Valantine H
    J Heart Lung Transplant; 2017 Sep; 36(9):1004-1012. PubMed ID: 28624139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Many heart transplant biopsies currently diagnosed as no rejection have mild molecular antibody-mediated rejection-related changes.
    Halloran PF; Madill-Thomsen K; Aliabadi-Zuckermann AZ; Cadeiras M; Crespo-Leiro MG; Depasquale EC; Deng M; Gökler J; Kim DH; Kobashigawa J; Macdonald P; Potena L; Shah K; Stehlik J; Zuckermann A
    J Heart Lung Transplant; 2022 Mar; 41(3):334-344. PubMed ID: 34548198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Novel High-throughput Droplet Digital PCR-based Indel Quantification Method for the Detection of Circulating Donor-derived Cell-free DNA After Kidney Transplantation.
    Verhoeven JGHP; Boer K; Peeters AMA; Clahsen-van Groningen MC; Roodnat JI; van de Wetering J; Nieboer D; Bost DA; Baan CC; Hesselink DA
    Transplantation; 2022 Sep; 106(9):1777-1786. PubMed ID: 35283452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rejection! Or is it? Correlation among molecular microscope diagnostic system, histopathology and clinical judgement following heart transplantation.
    Alam A; Van Zyl J; McKean S; Abdelrehim A; Patel R; Milligan G; Hall S
    Transpl Immunol; 2023 Dec; 81():101924. PubMed ID: 37648034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monitoring of Donor-Derived Cell-Free DNA by Short Tandem Repeats: Concentration of Total Cell-Free DNA and Fragment Size for Acute Rejection Risk Assessment in Liver Transplantation.
    Fernández-Galán E; Badenas C; Fondevila C; Jiménez W; Navasa M; Puig-Butillé JA; Brunet M
    Liver Transpl; 2022 Feb; 28(2):257-268. PubMed ID: 34407295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early findings after integration of donor-derived cell-free DNA into clinical care following pediatric heart transplantation.
    Feingold B; Rose-Felker K; West SC; Zinn MD; Berman P; Moninger A; Huston A; Stinner B; Xu Q; Zeevi A; Miller SA
    Pediatr Transplant; 2022 Feb; 26(1):e14124. PubMed ID: 34420244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The utilization of molecular microscope in management of heart transplant recipients in the era of noninvasive monitoring.
    Mehlman Y; Valledor AF; Moeller C; Rubinstein G; Lotan D; Rahman S; Oh KT; Bae D; DeFilippis EM; Lin EF; Lee SH; Raikhelkar JK; Fried J; Theodoropoulos K; Colombo PC; Yuzefpolskaya M; Latif F; Clerkin KJ; Sayer GT; Uriel N
    Clin Transplant; 2023 Dec; 37(12):e15131. PubMed ID: 37897211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.